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ABSTRACT
GLUTAMIC ACID DECARBOXYLASE s 
ISOLATION FROM BOVINE CEREBELLUM 
AND IMMUNOLOGICAL QUANTITATION 
IN DEVELOPING MOUSE BRAIN
by
RICHARD ALBERT HADJIAN
Glutamate decarboxylase catalyzes the formation of 
carbon dioxide and ^-aminobutyric acid from its substrate, 
L-glutamic acid. ^-Aminobutyric acid is an important in­
hibitory neurotransmitter in vertebrate and invertebrate 
nervous systems. L-Glutamate decarboxylase (GAD) is probab­
ly the rate limiting enzyme in determining steady state levels 
of ^-aminobutyric acid in normal nervous tissue. However, 
due to previously unsuccessful attempts to purify the enzyme 
to homogeneity, little is known with certainty about the de­
tailed properties of the enzyme.
A chromatographic procedure was developed to purify 
GAD from bovine cerebellum. However, only a 32-fold increase 
in enzyme specific activity could be obtained due to the en­
zyme's lability. Studies were made of the enzyme's thermal 
stability, pH optimum, inhibition by anions and carbonyl 
trapping agents, and effect on activity by its coenzyme pyr- 
idoxal-5'-phosphat e.
x
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
The purified enzyme preparation was analyzed on anal­
ytical acrylamide disc gel electrophoresis. The GAD band was 
identified by slicing, eluting, and assaying the gel slices 
for enzyme activity. The GAD band was then re-electrophoresed 
at various pH's and percentages of acrylamide to determine 
homogeneity of the band. A large scale gel procedure was 
undertaken to collect a sufficient quantity of electrophor- 
etically homogeneous GAD for production of antibodies by 
New Zealand White rabbits.
Monospecific antisera against bovine GAD were obtain­
ed from the rabbits. The antisera against GAD isolated 
from bovine cerebellum were found to react with the decarbox­
ylase of a bovine cerebellum and mouse brain with a single 
sharp precipitin line.
GAD enzyme specific activity was examined at various 
postnatal ages of developing mouse brain. An initial rise 
in GAD activity occurs at 6 days postnatally followed by a 
rapid increase in enzymatic activity which reaches a maximum 
at 28 days postnatally.
A quantitative measurement of the amount of GAD in 
developing mouse brain was performed. The quantitative im- 
munoprecipitation of GAD by rabbit anti-bovine GAD antisera 
indicates that the amount of protein in an immune precipitate 
perbrain increases 10-fold over the period between 1-28 days 
postnatally. Such an increase closely coincides with the 
GAD enzyme activity profile. Therefore, the increase in GAD 
enzyme specific activity during the postnatal development of
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
mouse brain represents an increase in the absolute amount 
GAD enzyme protein.
xii
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INTRODUCTION
Information processing in nervous systems is in all 
likelihood a result of a coordinated dynamic interplay be­
tween excitation and inhibition among neuronal systems. The 
presynaptic liberation of compounds that produce either an 
excitatory or inhibitory effect on the specialized postsyn- 
aptic regions of neural membranes is a form of cellscell 
communication. The disciplines of electron microscopy, 
physiology, biochemistry, and pharmacology have documented 
the existence of chemicals as the basis for cellular com­
munication in the nervous system. Presynaptic vesicles and 
synaptic clefts at neuronal junctions have been revealed by 
electron microscopy; a synaptic time-delay, characteristic 
of chemical diffusion, has been detected by physiological 
studies; and the demonstration of over a dozen chemicals, 
endogenous to nervous tissue, that can excite or inhibit 
neurons has been shown by biochemical and pharmacological 
studies.
A central concept is that contact at the outer neuronal 
membrane surface with various chemical substances produces 
physical changes in the membrane structure resulting in a 
change in the membrane’s permeability to small cations. 
Experimentally derived theories suggest the excitable mem­
branes affinity for the divalent cation, calcium, decreases 
via contact with an excitatory transmitter (see review by 
Koketsu sLl* i 1969)- Thus, conformational changes in the
1
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22+membrane ultrastructure caused by a loss of Ca permits the
entrance of Na and exit of K from the neuron. Depolariz­
ation is, therefore, a result of an excitatory effect. The 
inhibitory substances affect membranes by producing an in-
_ -f*
crease in K or Cl conductance, or by an electrogenic Na 
ion pump. A return to resting potential from the depolarized 
state is accelerated by this last event.
Data now implicates several naturally-occuring amino 
acids as putative excitatory or inhibitory transmitters 
(see review by Kravitz, 1967). Glutamic and aspartic acids 
may be excitatory transmitters and ^“aminobutyric acid (GABA) 
and glycine may be inhibitory transmitters. Thus, a com­
prehensive study of the properties and localization of the 
enzymes that are involved in the metabolism of these is ne­
cessary for forming hypotheses on the mode of action of the 
transmitters at a molecular level.
The only putative neurotransmitters whose localization 
in specific brain tracts have been established are the 
catecholamines, norepinephrine and dopamine, and the indole- 
amine, serotonin. The histochemical mapping of monoamine 
neurons in the brain (Hillarp gt.. al. , 1966) has led to the 
identification of catecholamine and serotonin tracts. Mono­
amine neuronal tracts occur as several separate and distinct 
tracts. Norepinephrine neuronal cell bodies occur primarily 
in the medulla oblongata, pons, and midbrain where their 
axons either descend in sympathetic columns of the spinal 
cord or ascend into the medial forebrain, primarily in the
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
3hypothalamus. Serotonin cell bodies are located in the raphe 
nuclei, a series of nuclei in the lower midbrain and upper 
pons. Serotoninergic axons follow the same pattern as those 
of the noradrenergic neurons. Dopaminergic neuronal tracts, 
unlike the preceding examples, are found more widely dis­
tributed, although they are highly concentrated in the sub­
stantia nigra, caudate nucleus, and putamen. A second dop­
amine tract occurs in the midbrain and a third in the hy­
pothalamus leading to the pituitary gland.
The rate of biosynthesis of the catecholamines is con­
trolled by a rate-limiting hydroxylation of their precursor, 
tyrosine, to form dihydroxyphenylalahine (DOPA). Tyrosine 
hydroxylase is found mainly in the catecholamine nerve ter­
minal and located in the cytoplasm (Nagatsu Qt_. al. , 196^). 
Thus, the initial step in the neurotransmitters * synthesis 
is outside the synaptic storage vesicles. That tyrosine 
hydroxylase activity can be inhibited by the catecholamines 
suggests the regulation of biosynthesis by a feedback inhi­
bition mechanism (Udenfriend, 1966). This implies that 
catecholamine synthesis would be enhanced to replace those 
which were discharged by nerve stimulation. Results of 
Alousi £t. al. (1966) indicate that the stimulation of per­
ipheral sympathetic nerves rapidly increases the formation 
of norepinephrine from tyrosine. Norepinephrine synthesis 
was not enhanced by addition of exogenous DOPA, thus in­
dicating that the initial step is the stimulated one. These 
results are consistent with the interpretation that tyrosine
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
4hydroxylase activity is stimulated by a release of feedback 
control without an increase in enzyme quantities. However, 
extended stress activates the synthesis of more enzyme 
(Alousi gi. ai., 1966).
Aromatic-L-amino acid decarboxylase (DOPA decarboxylase) 
converts DOPA to dopamine. It too is located in the cyto­
plasmic region of the catecholamine nerve terminal (Rodriquez 
et. al.. 196*0. Dopamine is subsequently hydroxylated by 
dopamine-^-hydroxylase, a copper requiring enzyme (Kaufman 
et. al.. I9 65)» whose locale is unestablished, to norepin­
ephrine. This enzyme is lacking in dopaminergic neuronal 
tracts where norepinephrine is present in negligible concen­
tration (Stjarne and Lishajko, 19 67)*
Catabolism of catecholamines is governed primarily by 
two enzymes. Monoamine oxidase (MAO) oxidatively deaminates 
dopamine or norepinephrine to aldehydic compounds; catechol- 
O-methyl transferase (COMT) methylates the catecholamine 
hydroxyl group in the meta position by the transfer of a 
methyl moiety from S-adenosylmethionine (Axelrod, 1965). 
Methylation by COMT may also proceed on the aldehyde compouncfe 
formed by MAO. Thus, both MAO and COMT are non-specific 
monoamine degrading enzymes.
Dopamine is, specifically, methylated by COMT to 3-°- 
methyl dopamine, which is deaminated to *l— hydroxy-3 -met hoxy 
phenylacetic acid (homovanillic acidiHVA). The measurement 
of HVA in the cerebrospinal fluid is used as an indicator of 
the activity of dopaminergic neurons. Degradation of nor-
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
5epinephrine proceeds either by COMT to normetanephrine or by 
MAO to a glycoaldehyde. The glycoaldehyde is then reduced 
by alcohol dehydrogenase to a glycol, or oxidized by aldehyde 
dehydrogenase to mandelic acid. These by-products are then 
methylated by COMT; the glycol compound is converted to 
3-methoxy-i(— hydroxylphenylglycol (MHPG) in the central ner­
vous system (CNS); mandelic acid to an O-methylated acid, 
vanillymandelic acid (VMA) in the peripheral nervous system. 
VMA in urine is measured as a clinical index of sympathetic 
nervous function.
The functioning of the two major transmitter degrading 
enzymes, COMT and MAO, is elucidated by their subcellular 
localizations. MAO is found in the outer mitochondrial 
membranes of the catecholaminergic nerve terminal. Thus, 
catecholamines that either leak out of storage vesicles 
into the cytoplasm or are taken up from the synaptic cleft 
are metabolized before acting on postsynaptic sites (Axelrod, 
1965)« Although COMT distribution appears to correlate with 
endogenous catecholamines (Axelrod al* » 1959)» the en­
zyme does not appear to be present in catecholaminecontain- 
ing nerve terminals, since COMT activity is not reduced after 
sympathectomy (Potter a£. aX* » 1965)* This is consistent 
with the interpretation that extraneuronal COMT acts on 
norepinephrine discharged into the synapse, but not that 
norepinephrine inactivated by the reuptake process (see 
review by Snyder, 1967)*
Synaptically discharged catecholamines are inactivated
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
6by reuptake into presynaptic nerve terminals, not by the 
method of enzymatic degradation (Iversen, 1967)* The cat­
echolamine reuptake process was discovered by Axelrod (1965) 
when intravenously injected radioactive norepinephrine was 
found in synaptic vesicles. Metabolic inhibitors and low 
temperatures depress reuptake. The process functions optim- 
ally at physiological concentrations of Na and K , is sat­
urable, obeys Michaelis-Menten kinetics, and is inhibited 
by ouabain, an inhibitor of (Na , K )-ATPase (Tissari at. 
al.. 1969)* The reuptake-storage process may be disrupted 
by the drug reserpine (Euler and Lishajko, 1 9 6 3), which re­
leases norepinephrine from the presynaptic catecholaminer- 
gic vesicles (Iversen, 196?), or by the tricyclic anti­
depressant imipramine which blocks reuptake from the syn­
aptic cleft (Snyder, 1967).
Serotonin (5-hydroxytryptamine) is formed from an es­
sential amino acid, tryptophan. Tryptophan is first hy- 
droxylated to 5-hydroxytryptophan (5-OH-trp) by tryptophan 
hydroxylase (Ichiyama si* ai, 1970)1 which unlike tyrosine 
hydroxylase, has not been clearly established as a rate- 
limiting enzyme. 5-OH-trp is then decarboxylated to ser­
otonin by aromatic-L-amino acid decarboxylase which may be 
the same enzyme as DOPA decarboxylase (Lovenberg et. al. , 
1962; Udenfriend si* ai** 1970 and 1971)* The evidence 
for feedback inhibition on tryptophan hydroxylase by ser­
otonin is weak (Eiduson, 1966).
The inactivation of serotonin is similar to the pro­
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7cess for catecholamines, that is by a specific reuptake sys­
tem operating at the level of the neuronal membrane. This 
reuptake process was first thought to be unique for the cat­
echolamines, however it now appears to be a universal method 
for inactivating compounds after they have acted as neuro­
transmitters, and that acetylcholine’s enzymatic breakdown 
is the unusual situation. Acetylcholine is removed, after 
its interaction with the postsynaptic receptor site, by a 
rapid hydrolysis via acetylcholinesterase.
Evidence for glutamate, glutamine, and aspartate as 
neurotransmitters is still incomplete. Early studies de­
monstrated that D-glutamate and D-aspartate were both potent 
inducers of spreading cortical depression in the rabbit, 
and contraction of crustacean muscle (Van Harreveld, 1959)*
At present, however, the rationale for a transmitter role 
at primary sensory nerve endings in the spinal cord rests 
on (l) a greater concentration of glutamate in dorsal rather 
than ventral regions of the spinal cord (Duggan and Johnston, 
1970), and (2) an excitatory effect by direct application 
of glutamate to spinal motor neurons (Krnjevic, 1965)* The 
fulfillment of specific criteria for a neurotransmitter* 
synthesis, storage, release, postsynaptic action, and inac­
tivation are either general or unestablished.
It is possible that the amino acids, glutamate, gluta­
mine, and aspartate may serve as a link between metabolism 
and function in nerve cells (Huggin al. al., 1 9 6 7)* During 
the early and rapid growth phase of the brain in both cat
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
8(Berl fi£. al. , 1963) and ra-t (Bayer si., al. , I967)* glutamate 
concentration increases two-to threefold, while glutamine 
remains fairly constant. The synthesis or glutamate and 
glutamine is a major pathway for reducing local levels of 
ammonia (Krebs, 1935)» (Berl et. al., 1962). The major cause 
of the encephalopathy associated hepatic disease is an el­
evation of blood ammonia levels. Hyperammonia in blood has 
been shown experimentally to be epileptogenic and to pro­
duce coma rapidly (Schenker et. al., 1965). Review articles 
showing the possible correlation of the metabolism and function 
of these compounds have been written (Waelsch, 1951> Curtis 
et. al. . 1965; and Curtis et.. al. , 1970).
Although glycine is simple structurally, its intermed­
iary metabolism and functional role in the nervous system 
is complex. Glycine has been shown to be present in large 
amounts in the CNS (Aprison si. aJL., 19 68), and pharmacol­
ogical and electrophysiological evidence support its role 
as an inhibitory transmitter in the spinal cord of cat 
(Werman si. , 1968). Evidence is accumulating for its
1 ix
presynaptic release from isolated perfused ( C-glycine) 
toad spinal cord during stimulation of the dorsal roots 
(Aprison, 1970). Also, a relationship exists between the 
number of neurons involved in polysynaptic inhibitory re­
flexes and glycine content (Davidoff et. al., 1967). Work 
with the convulsant, strychnine, further supports glycine's 
inhibitory role, since by its normal blocking of the post­
synaptic inhibition of motor neurons, strychnine antagonizes
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
9the action of glycine. Presumably strychnine interferes 
with postsynaptic membrane's receptor site for glycine 
(Curtis fit.. al» 1968). A high-affinity transport process 
for glycine from the synaptic cleft has been found in spinal 
cord (Neal fi£. al., 1969).
GABA is an established inhibitory transmitter at the 
crustacean neuromuscular junction (Kuffler et.. al.. , 195$) 
where it is almost exclusively localized within inhibitory 
axons and nerve cell bodies (Otsuka et. al. , 1 9 6 7). GABA 
levels are 100 times greater, and glutamic acid decarboxylase 
(GAD) (EC ^.1.1.15) is 10 times higher in inhibitory axons 
and nerve cell bodies, than in corresponding excitatory neur­
ons (Kravitz fit., al. , 1965). Evidence suggests that GABA 
may affect the release of transmitter from excitatory nerve 
terminals and cause an increase in Cl” permeability at the 
postsynaptic membrane (Takeuchi si. al., 1966).
Although evidence is less complete, GABA is probably 
a major inhibitory transmitter in the vertebrate nervous 
system (Roberts at. al., 1968), as well as the invertebrate. 
Applied directly to the brain of mammals GABA has a non­
specific depressant action (Bhargava at. ai* » 196*0. Its 
regional distribution in vertebrate brain is compatible 
with its inhibitory transmitter role; in rabbit cerebellum 
GABA concentration is highest in the inhibitory Purkinje 
cells (Kuriyama at. al • » 1966).
The formation and metabolism of GABA in the nervous 
system involves a major pathway in the brain. In the CNS
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
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of vertebrate organisms GABA is formed by an irreversible 
decarboxylation of L-glutamic acid. GAD catalyzes this 
reaction requiring pyridoxal-5'-phosphate (PyP) as a co- 
enzyme. Regional levels of GAD accurately reflect regional 
levels of GABA not only in guinea pig brain, but also in other 
species (Sisken si* al[, i960). Such a reliable correlation 
between enzyme activity and substrate concentration substan­
tiates the concept of GAD as being the major pathway to GABA 
in nervous tissue.
GABA degradation is via a reversible transamination with
c^-ketoglutarate (c^-KG) as the amino group acceptor. The
reaction is catalyzed by GABA-oC-ketoglutarate transaminase
(GABA-T) to form glutamate and succinic semialdehyde (SSA).
GABA-T is a pyridoxal phosphate requiring enzyme, as is GAD
(Baxter si* al., 1958) and is found chiefly in the gray
matter of the CNS (Fahn si. a^ L. , 1968), (Salvador et.. al. .
1959)* In contrast to GAD, GABA-T appears to be a mitochon-
drially-bound enzyme, of which 20% of its activity resides
in the presynaptic nerve terminal (Salganicoff et. al.. 1965),
(Reijnierse si* ai* * 1975)* Intraperitoneally injected 
1 ^U—( C)GABA is rapidly metabolized and label is found in 
respired COg, tricarboxylic acid (TCA) cycle intermediates, 
and related amino acids (Wilson si* aJL* , 1959)* The final 
reaction of GABA degradation is the conversion of SSA to 
succinate, which enters into the TCA cycle, via succinic 
semialdehyde dehydrogenase. The enzyme has been studied 
in detail in humans (Embree si* ai* » 1964) and has a local-
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
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ization similar to that of GABA-T, that is in the mitochondria 
of all neuronal regions (Miller ei. §JL. , 1967). These in­
dividual enzymatic steps constitute the "GABA shunt”, which 
represents an alternative pathway to the portion of the tri­
carboxylic acid cycle between °<-KG and succinate. The net 
effect of the shunt is the conversion of ® < - K G  to succinate 
with the evolution of CO^ and the reduction of NAD. However 
only three ATP equivalents are generated by the shunt as 
compared to four ATP equivalents by the Krebs cycle. In 
guinea pig cortical slices the "GABA shunt" is completely 
dependent on the presence of GAD and GABA.
Presynaptic release of GABA has been demonstrated by 
stimulation of inhibitory axons to various lobster muscles 
(Otsuka si. ., 1966). Stimulation of excitatory axons have 
no effect on GABA release. GABA release in vertebrate ner­
vous system has been more difficult to establish. However, 
its release has been found from the posterior lateral gyri
of cats during synaptic inhibition (Mitchell si. al., 1969).
3
Release of -'H-GABA from pre-loaded cortical slices of rat 
brain has also been effected by high K concentration (Srinivasan 
Si. al., 1969).
An ionic basis for the inhibitory mechanism of action 
of GABA on presynaptic membranes of invertebrate and verte­
brate neurons has been postulated (Roberts ei. al. , 1968 and
i960). GABA acts at the presynaptic membrane of crayfish 
by increasing the permeability to Cl" (Dudel ei. al., 1961) 
thereby inhibiting the release of excitatory neurotransmitters
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
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(Takeuchi et. gl. , 1966).
Inactivation of GABA at the synaptic cleft probably pro 
ceeds by a transport to intracellular sites. Enzymatic de­
gradation of GABA is unlikely since GABA-T has a intracellular 
mitochondrial location and thus is not close to the synaptic 
membrane. One theory postulates a high-affinity uptake of 
free extraneuronal GABA at membranes and requires a high Na 
(0.1 M) environment (Roberts g£. al., 1968). It is proposed 
that GABA is transported to the intracellular medium by a
•f
carrier-mediated transport system utilizing an active Na 
gradient coupled to a utilization of ATP. This uptake sys­
tem would serve to terminate the action of GABA by the removal 
of GABA from sites of action in the synapse and its subsequent 
mitochondrial metabolism (Roberts gt. al., 1 9 6 8).
The purification and isolation of mammalian GAD from 
brain extracts has remained a difficult task because of its 
extremely unstable nature. A major purification has been 
accomplished by using buffers containing PyP at 0.1 mM and 
aminoethylisothiouronium bromide at 1 mM (Susz gt. al., I9 6 6). 
This results in a protection of sulfhydryl and/or other labile 
reactive groups on the apoenzyme. The only proven procedure 
uses 9»000 mouse brains to obtain a crude mitochrondial 
fraction followed by fractionation on DEAE-Sephadex, Sephadex 
G-200, (NH^)2S0^ fractionation and calcium phosphate gel 
chromatography. This procedure has resulted in a 600-700 
fold purification of GAD (Wu g£.. al. , 1973? Roberts g£.
SJL. t I963). The enzyme's pH optimum varies during the pur-
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ification from 6.4 at the first stages, to 7.2 at the final 
stage; likewise the Km changes from 0.003 to 0.008 (Wu et. 
al. . 1973). Both of these shifts suggest conformational 
changes in the protein during the purification procedure.
The enzyme remains moderately stable at temperatures below 
40° C.
Mammalian GAD can be inhibited both in general and specific 
manners. Halogen anions such as Cl“ inhibit the protein at 
50 mM concentrations, suggesting that there could be reg­
ulation of the enzymatic activity by the ratio of glutamate 
to GABA at particular inhibitory neural junctions (Roberts 
et. al., 1968). Sulfhydryl reagents and oxidation are potent 
inactivators of mammalian GAD in vitro (Roberts et., al. , 1963)» 
however this may be prevented by SH-protective agents such 
as glutathione. Estrogens, salicylate, and phenolic com­
pounds are also inhibitors of GAD (Tashian, 1961).
On the basis of available data for GAD and other pyridoxal 
phosphate-dependent enzymes hypotheses have been made on the 
coenzyme's linkage to GAD. This information suggest an 
aldimine linkage of pyridoxal phosphate to two £ -amino 
groups of lysine (Roberts g£. al., 1964). Compatible with 
this theory are both spectral data and in vitro work with 
PyP analogues and carbonyl trapping agents. The carbonyl 
trapping agents presumably interact with the aldehyde group 
of PyP and possibly with amino acid residues of the apoenzyme. 
Specific carbonyl trapping agents such as hydroxylamine and 
aminooxyacetic acid inhibit GAD only in vitro: in vivo they
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potentiate GAD inhibition by pyridoxal hydrazone formation 
(Tapia si. al. , 1967)* Hydrazine, hydroxylamine, and pyr­
idoxal semicarbazone are 100 times more potent inhibitors 
of pyridoxal kinase, which mediates the synthesis of PyP 
from pyridoxal and ATP (McCormick e£. al., i960), than GAD 
in vitro. Thus, if free PyP were reduced (6k% of control) 
by inhibition of pyridoxal kinase, the activity of GAD with 
its relatively weak affinity for PyP would be affected. Tapia 
(1973) has shown a correlation between a decrease in PyP and 
GAD activity (2$% of control) after administration of pyridoxal- 
5 '-phosphate- $ -glutamyl hydrazone (PyPGH). Tapia (1969) 
suggesls that after PyPGH treatment the following sequence 
of events occurs in the nerve endings inhibition of pyridoxal 
kinase decrease of levels of PyP inhibition of GAD de­
creased rate of GABA synthesis convulsions. Thus a decrease
in the critical concentration of PyP would result in less 
GABA, the putative inhibitory transmitter.
GAD activity has been determined by either the rate of 
COg release or the rate of GABA formation. The evolution 
of COg is usually measured by manometric, spectrophotometric, 
or isotopic techniques. GABA formation rates have been 
measured by two-dimensional paper chromatography and high- 
voltage paper electrophoresis (Smith, i960) or enzymatically 
(Hakkinen and Kulonen, 1963). However, none of these methods 
facilitate the handling of large numbers of samples.
Cozzani (1970) developed a spectrophotometric assay for 
a kinetic study of GAD from Clostridium perfringens^ The
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assay is accomplished by the addition of the "Gabase System*', 
GABA transaminase coupled to succinic semialdehyde dehydrog­
enase. The actual sequence of the coupled enzyme reaction 
is *
L-glutamate  ^GABA + C02
GABA + o(-KG + NADP+ + U^O ^succinate + glutamate + NADPH + H+
Thus, the velocity of the enzymatic removal of the oi -carboxyl 
group from L-glutamate is estimated from the rate of reduction 
of NADP*.
An automated PC°2 (partial pressure) assay for GAD 
(Zeman ££. al., 1973) has been developed which is based on 
the measurement of the partial pressure of C02 in a reaction 
mixture as a measure of total C02 formed by enzymic decar­
boxylation of glutamate.
C02 liberated at acidic pH is usually measured by con­
ventional manometric techniques in a Warburg apparatus.
First described in 1951 "by Roberts and Frankel the method 
uses a high specific activity radioactive substrate and the 
measurement of liberated C02. The technique has undergone 
refinements and is now the method of choice for the measure­
ment of GAD enzyme activity. Under the proper conditions 
(Roberts and Simonsen, 1963)* the techniques allows for
1 /j,
essentially complete absorption of C02 by Hyamine.
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lij.
The original method for absorbing and counting CC>2 by- 
liquid scintillation spectrometry (Passman g£. al., 1956) 
was modified for use with substrates of high specific ac­
tivity to detect as little as 10 ^  moles of COg. This 
microradiometric technique was established by Albers and 
Brady (1959) to permit analysis of large numbers of samples 
with a minimum of manipulation. The vessels for this reaction 
have been modified repeatedly (Wilson et. al. , 19721 Moskal 
and Basu, 1975)* The assay method for the experiments 
presented in this thesis are discussed in the Methods sec­
tion.
Comparative studies with GAD from crustacean nervous 
tissue show both similarities to and differences from the 
mammalian enzyme (Molinoff gt. al. , 1968). While the mouse 
enzyme is not affected by a feedback regulation by GABA, 
the lobster enzyme is inhibited by GABA (Ki calculated as 
1.25 x 1(T3 M GABA, Roberts gt.. al. , 1963). This feedback 
regulation may control the production of GABA at lobster 
inhibitory synapses while Cl“ may fill this role in the 
mammalian system (Roberts gi. al*, 1968). Halogen anions 
do not affect lobster GAD, but K is required, unlike the 
mammalian enzyme.
The developmental relationship between GAD and GABA have 
been examined in the brains of mice, rats, chickens, cats, 
dogs, and bullfrogs. In all these systems, and within 
specific brain areas, enzyme and substrate levels progress­
ively increase until mature levels are reached, The age of
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increases in both GAD activity and GABA levels coincide with
the period of rapid growth of the surface area of cortical
dendrites in rabbit (Agrawal gt. al., 1967)*
Regional distribution of GAD in the CNS of several
mammalian species, including man, has been studied (Muller
et. al.. 1962). Autoradiographic distribution patterns of 
1 ii
2- C-GABA, injected stereotaxically into rats, indicate that 
areas of gray matter contain the highest levels of GAD. In 
rabbit, GAD is found in the inhibitory synapses of the 
Purkinje cell layer (Kuriyama gt. gl., 1966). The dorsal 
gray matter of cat has twice the GAD level as the ventral 
region (Graham gi. al., 1969).
Data regarding the subcellular distribution of GAD can be 
perplexing. Differential centrifugation of crude brain 
homogenates indicates GAD migrates with the crude mitochon­
drial fraction (Shatunova gi. al., 196^). However, osmotic 
shock which releases the GAD from the particulate fraction 
without irreversibly damaging mitochondria indicates that 
GAD is a cytoplasmic enzyme localized mainly in the presyn- 
aptic nerve terminal axoplasm (Salganicoff gi. al., 1965) •
It also appears that the amount of GAD released by osmotic 
shock is Sa dependent. A concentration of k mM GaClg 
prevents substantial release of GAD into the supernatant
fraction. The quantity of GAD released increases when a
2+chelating agent for Ca , or a membrane dispersant such as
Triton X-100 are used (Salganicoff gi. al., 1965)* These
2+results on the fixation of the enzyme by Ca suggest that
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2+the Ca present in nerve endings is probably sufficient to 
promote GAD binding to the outer surface of synaptic vesicles. 
Thus, GABA formed may diffuse into the axoplasm or be collected 
within the synaptic vesicle. This situation would be similar 
to the synthesis of acetylcholine by choline acetylase, an 
enzyme attached to the synaptic vesicle's surface (Ritchie 
and Goldberg, 1970)* Immunocytochemical localization of GAD 
in developing rodent cerebellum indicates the enzyme is in 
close association with synaptic vesicles and at presynaptic 
junctional membranes (McLaughlin et. al. . 1975)*
The present work describes an isolation procedure for 
bovine cerebellum GAD via column chromatography and acryl- 
amide gel disc electrophoresis. Monospecific antibodies 
for GAD were obtained, and subsequently quantitative mea­
surements of the amount of GAD in developing mouse brain 
were performed. This allowed us to determine if the in­
crease in GAD activity during development was due to an 
increase in the quantity of enzyme, or an enhancement in 
activity of existing enzyme.




The mice in all developmental experiments were C57BL/6J, 
originally obtained from Jackson Laboratories, Bar Harbor, 
Maine, and maintained by brother x sister matings. Food 
(Charles River) and water were available ad libitum: mice
were maintained with a 1^ hour light, and 10 hour dark per­
iod. The temperature of the mouse facility is 72° F =h 2° 
with a relative humidity of 50 Hr 5
Bovine brains were obtained from the Granite State 
Packing Co., Manchester, New Hampshire; human brains were 
obtained from the Massachusetts General Hospital, Boston, 
Massachusetts. Bovine brains were removed as soon as possible 
after death of the animal and stored on ice until returned 
to the laboratory. Meningeal membranes were removed from 
the brains and brains were stored at -20° C,
New Zealand White rabbits were obtained from Camm Re­
search Institute, Wayne, New Jersey. Food (Agway, Inc. ) 
and water were available al libitum: rabbits were main­
tained similarly to mice.
All chemicals used were reagent grade.
Glutamate Decarboxylase Assay
A modification of the method of Wilson s±. a!« » 1972, 
was employed. Substrate, L-(l- C)glutamic acid, was ob-
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tained from Calatomic, Inc., Los Angeles, California and
O 1 11-
stored at -20 C prior to use. Solid L-(l- C)glutamic acid 
was dissolved in 2.5 ml of 50 mM potassium phosphate buffer, 
pH 6.8, 1 mM dithiothreitol (DTT) prior to use. Non-radio­
active glutamic acid was added to give a specific activity 
of 20 mCi/mmole. Each reaction contained the following com-
i / i .
ponents in a final volume of 100 ^1: 10 j^ l, 5 mM L-(l- C)-
glutamic acid (1 ^Ci per reaction) dissolved in 50 mM potass­
ium phosphate, pH 6.8, 1 mM DTT (buffer A); 10 pi, 1 mM
pyridoxal-5'-phosphate (Sigma) in buffer A; 80 pi, brain 
homogenate or a dilution thereof. Reaction mixtures were 
sealed in 17 x 120 mm conical glass centrifuge tubes with 
tightly fitting rubber stoppers holding a plastic cup (Ace 
Glass). The plastic cup held a number 0 gelatin capsule 
(Lilly) containing 0.2 ml of 1 M Hyamine hydroxide in 
methanol. Addition of the reaction components was done with 
the vials kept on ice. Reaction tubes were then transferred 
to a shaking water bath and incubated for 30 min at 37° 0. 
Reactions were stopped by injection of 100 pi of 2 M glacial 
acetic acid through the rubber stopper; complete absorption
i Ll
of COg by the Hyamine solution was allowed for 30 mm.
The rubber caps were then removed and the gelatin capsules 
removed with forceps and placed in a scintillation vial 
containing 10 ml of toluene-fluor scintillation mixture.
The toluene and fluors solution was prepared by dissolving 
50 grams PP0 (2,5-diphenyloxazole) and 0.625 grams P0P0P 
(p-bis(5-phenyloxzolyl-2-)-benzene) in 500 ml of reagent
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grade toluene. The final liquid scintillation solution was 
prepared by adding 42 ml of the above solution to 1 liter 
of toluene. Background fluorescence was reduced by addition 
of 1 ml glacial acetic acid to this solution. Radioactivity 
was determined in a Nuclear Chicago Mark II liquid scin­
tillation counter. Where noted counts have been left as CPM,
1/i,
since the efficiency of C counting as determined by the 
external standard method remained constant.
Glutamate Decarboxylase Partial Purification 
Preparation of Starting Material
Bovine Cerebellum was thawed and homogenized (Osterizer 
blender) in buffer A (2 ml per gram wet weight). The 
homogenate was centrifuged at 35»000 x g for 20 min at 4° C 
in a Sorvall centrifuge. The supernatant was dialyzed 
overnight at 4° C. At each stage in the protocol a protein 
determination (Warburg and Christian, 1942) and a GAD assay 
was performed.
First DEAE-Sephadex Column
The dialyzed sample (see Fig. 2 for details) was load­
ed onto a DEAE-Sephadex A-50 column (2.5 x 50 cm) that had 
been previously equilibrated with buffer A. An equal volume 
of buffer A was introduced after the sample. A linear 
gradient elution system consisting of 250 ml of 0.1 M 
potassium phosphate, pH 6.8, 1 mM DTT, and 250 ml of 0.6 M 
potassium phosphate, pH 6.8, 1 mM DTT was used. The flow
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rate of the effluent, 0 .5 ml per minute, was kept constant 
by the use of a peristaltic pump and 4 ml fractions were 
collected. All work was done at 4° C. The highest specific 
activity fractions were pooled and dialyzed overnight against 
buffer A.
Second DEAE-Sephadex Column
DEAE-Sephadex A-50 (2.5 x 50 cm) was equilibrated with 
buffer A. The enzyme solution from the preceding step was 
then applied (see Fig. 3)» followed by an equal volume of 
buffer A. The batchwise elution system consisted of the 
following buffers s
1. 100 ml, 0.1 M potassium phosphate, pH 6.8 ; 
containing 1 mM DTT,
2. 400 ml, 0.2 M potassium phosphate, pH 6.85  
containing 1 mM DTT.
High activity fractions were pooled and dialyzed against
2 volumes of buffer A overnight with one change.
PM-3 0 Concentration
The dialyzed sample was concentrated to approximately 
14 ml under Ng (30 psi) using a PM-30 Diaflow pressure ultra­
filtration membrane (Amicon).
Gel Filtration on a Sephadex G-100 Column
The concentrated enzyme was applied to a Sephadex G-100 
column (1.5 x 100 cm) previously equilibrated with buffer A. 
The column was eluted with buffer A at a flow rate of 10 ml
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per hour, kept constant by the use of a peristaltic pump.
4 ml fractions were collected. Highest specific activity 
fractions were pooled and aliquots stored at -20° C.
Isolation and Radioactive Assay of GAD on Polvacrvlamide Gels 
Electrophoresis was performed in a Hoeffer apparatus 
using a discontinuous buffer system (Davis, 196*0. The 
standard anodic gel system stacking at pH 8.9 and running 
at pH 9 .5 was used, with the only exception being the sub­
stitution of a Tris-phosphoric acid buffer in place of the 
usual Tris-HCl. Separating gels were initially run for one 
hour in a continous buffer system (a 1:8 dilution of Tris- 
phosphoric acid buffer) to eliminate oxidation contaminants 
of gel polymerization. Gels were run at the following per­
centages of acrylamide, 3*5* 5«2 5 * 7.0, 10.5* with the 3*5^ 
gel providing the clearest separation of the GAD band from 
other proteins. Tubes were 12 cm long and 5 mm inside di­
ameter, and contained 5 cm of separating gel and 0.5 cm of 
stacking gel. The gels were run at constant current of 1.5 
mA/gel at 4-° C. Bromophenol blue was used as a tracking 
dye and the gels were run until the dye front was 5 mm from 
the end of the gel; the gels were removed and the dye front 
marked with a wire. The gels were then quick-stained with 
Buffalo Black solution at 90° C for 20 min, destained elec- 
trophoretically for 20 min in 7 °/° acetic acid, and left in 
a diffusion destainer (in 7 ^ acetic acid) until all back­
ground staining was eliminated. Quantitation of the amount
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of GAD protein was done by running known concentrations of 
bovine serum albumin on gels and comparing densitometric in­
tegrator units to those obtained for GAD as determined by 
a Joyce-Loeble densitometer.
The determination of the migration position of GAD in 
polyacrylamide gels was accomplished by enzyme assay of 
slices from unstained gels. After electrophoresis the 
proteins were visualized by immersing gels in a 0.003 % 
solution of l-anilino-8-napthalene sulfonate (ANS) (Hartman 
et. al., 1969) under a ultraviolet lamp. The distance of 
bands from the dye front was measured. Another gel was cut, 
starting at the dye front, into 2-mm slices. Each slice was 
placed into GAD assay tubes containing 0.5 nil, 0.1 M potassium 
phosphate, pH 6.6, 1 mM DTT, and 1 mM PyP. They were shaken 
in an ice bath for 2 hours and frozen at -20° C. After 
thawing 10^Ci of L-(l-^C)glutamic acid was added to each 
gel slice solution, followed by a 60 min incubation at 37° C. 
Enzyme activity coincided with one major protein band, as 
positioned by ANS.
Re-electrophoresis of GAD was performed by homogenizing 
(Duall homogenizer, Kontes Glass Co.) two gel slices in 0.37 
ml of buffer A, followed by electrophoresis as described 
above, at multiple pH's and percentages of acrylamide.
Rabbit Immunization and Immunochemical Analysis
Rabbits were injected with electrophoretically pure 
GAD. The following injection protocol was followed: 250
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j^ g of homogenized GAD protein contained in the gel slices 
was emulsified with 6 ml of Freund's complete adjuvant (Miles 
Laboratories, Inc.); Injections were distributed among 5 
intradermal sites in the back, hind toe pads, and thigh 
muscles; 250 y^ g suspensions in Freund's incomplete adjuvant
4" V» 4“
were injected intramuscularly on the 10 and 20 day; a 
100 j^ g injection was given on day 30. Rabbits were bled 10 
days after the final injection. Rabbits were bled by ear vein 
periodically to determine the extent of antibody production. 
Sera were collected by allowing the blood to coagulate at 
-^° C then pouring off the clear amber sera and storing it 
at -20° C. Monospecificity of the rabbit anti-bovine-GAD sera 
was tested on micro double immunodiffusion plates (Hyland, 
pattern C). Antisera were tested against bovine and mouse 
brain homogenates, and the most highly purified bovine GAD. 
Development of plates was made at 4° C.
Quantitative Immunoorecioitation of Mouse GAD
Mice at various postnatal ages were killed by decapita­
tion, their brains removed, weighed, and stored at -20° C.
The brains were homogenized in a Duall homogenizer in buffer 
A (2 ml per gram wet weight), centrifuged at 35* 000 x g for 
20 min at k° G. The supernatant was assayed for GAD activity 
and utilized for quantitative immunoprecipitation.
The following assay procedure was utilized* increasing 
concentrations of immune sera between 20-100 A 1 were diluted 
to a constant volume of 100 xl with distilled water, to
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which a constant volume (1 5 ^ 1 ) of the mouse brain 35iOOO x g 
supernatant fraction was added. The solutions were shaken for 
60 min first at room temperature, then at C. They were 
centrifuged (International, Model PR-2) at 1,000 RPM for 10 
min at k° C to pellet the antigen-antibody complex. The 1,000 
RPM supernatant (80 ^1 aliquot) was assayed for GAD activity. 
The pellet was washed 3 times with buffer A and its protein 
concentration determined by the Lowry method, modified by 
Oyama and Eagle, (1956).
For developmental studies mouse brain 35»000 x g super­
natant fractions from various ages were adjusted to 4 mg 
protein/ml. Quantitation of GAD by immunoprecipitation was 
performed essentially as described above, with the following 
modification* increasing concentrations of immune sera between 
10-70 3^ 1 were diluted to a constant volume of 70 >*1 with dis­
tilled water, to which 50 3\1 of a brain extract was added.




The GAD enzyme activity assay was based on the evolu-
lif.
tion, and subsequent absorption of C02 by a Hyamine hy-
lU’droxide solution. The efficiency of C counting by the 
external standard method was constant at 90-9^7° efficiency, 
therefore all counts were left as CPM. The use of gelatin
capsules to hold the Hyamine solution does not affect the
In­efficiency of C counting. The decarboxylation of radio-
in­active substrate (L-(l- C)glutamic acid) was first studied
to establish its linearity with respect to protein concen­
tration of a bovine brain extract. The extract used was 
prepared as described in Methods. Figure 1 indicates that 
GAD activity is proportional to protein concentration over 
a thirty-three fold range. This linear increase in GAD 
activity with respect to protein concentration was highly 
reproducible and re-checked for all extracts studied to in­
sure the validity of the assay method.
Partial Purification of GAD 
In a typical preparation 200-250 ml of a crude bovine 
cerebellum extract was dialyzed overnight versus an excess 
of standard buffer A to reduce endogenous levels of brain 
glutamate. This dialyzate was put on a DEAE-Sephadex A-50 
column. Fractions were assayed for A2gQ and GAD activity. 
Figure 2 shows the a2q0 and GAD activity of the eluant
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Fig. 1. GAD enzyme activity with respect to protein 
concentration of a bovine brain extract
The bovine cerebellum extract was prepared as des­
cribed in Methods.
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Fig. 2. Elution profile of the first DEAE-Sephadex 
column
220 ml of dialyzed bovine cerebellum extract was put 
onto a DEAE-Sephadex A -50 column (2,5 x 50 cm). The column 
was eluted with a linear gradient between 0.1-0. 6 M potassium 
phosphate (pH 6.8 ), 1 mM DTT, at a flow rate of 30 ml/hr and 
^ ml fractions were collected. -^280 ^ ^
( — ).
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from the first DEAE-Sephadex column. The bulk of the ^ 8 0  
material elutes within the two initial peaks, between frac­
tions 20 and 90, while all the GAD activity elutes in a 
single peak at approximately 0 .2 M phosphate buffer. Frac­
tions showing the highest GAD specific activity were pooled 
and dialyzed overnight to reduce phosphate concentration 
to that of the standard buffer (50 mM). This initial pro­
cedure yields a 16-fold purification of the enzyme.
The dialyzed fraction, 50-75 ml, was then loaded onto 
the second DEAE-Sephadex A-50 column. Figure 3 show the 
"^280 and activity of the eluant from the second DEAE- 
Sephadex column. The bulk of the ^280 ma'fcerial elutes in 
the first peak and GAD is found exclusively in the second 
peak around fraction number 12"5. The fractions with the 
highest GAD activity were pooled, dialyzed overnight, and 
concentrated using a PM-30 Diaflow ultrafiltration membrane.
The PM-30 concentrate, 10-15 ml, was put on a Sephadex 
G-100 column (1.5 x 100 cm). Figure ^ shows the A280 and 
GAD activity profile of the eluant of the Sephadex G-100 
column. Protein eluted in two approximately equal peaks 
and GAD activity was found midway between these two peaks.
GAD activity, which eluted around the fourteenth fraction, 
was pooled and this fraction was labeled as partially pur­
ified bovine GAD.
Table 1 shows that the chromatography protocol results 
in an approximate 3 2-fold purification of the bovine enzyme 
and approximately a 7°/o recovery of starting GAD enzyme activity.
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Fig. 3 . Elution profile of the second DEAE-Sephadex 
column
65 ml of the dialyzed pool from the first column was 
put onto a second DEAE-Sephadex A-5 0 column (2.5 x 50 cm).
The column was eluted with a batchwise elution system, 0.1 M 
then 0.2 M potassium phosphate, pH 6 .8 , 1 mM DTT, at a flow 
rate of 30 ml/hr and ^ ml fractions were collected. -^280 
(--- ); GAD activity (---).
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Fig. k. Elution profile of the Sephadex G-100 column
2 2 .5 ml of the dialyzed pool from the second column 
was concentrated (PM-3 0 Diaflow pressure ultrafiltration) to 
14.5 ml and was put onto a Sephadex G-100 column (1.5 x 100 cm). 
The column was eluted with 50 mM potassium phosphate (pH 6.8 ),
1 mM DTT at a flow rate of 10 ml/hr and k ml fractions were 
collected. ^280 ^ ac't^ v^’*:y ^--
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TABLE 1. STEPS IN THE PARTIAL PURIFICATION OF
GLUTAMATE DECARBOXYLASE FROM BOVINE BRAIN









Crude Extract 227 20.6 4676 2.27 515.3 0.11 100
Dialyzate 220 11.0 2420 1.87 411.4 0.17 80 1.5
DEAE-S ephadex 65 1.56 101 2.70 175.5 1.74 34 15.8
DEAE-Sephadex 22.5 1.32 29.7 3.00 67.5 2.27 13 20.6




Further attempts at purification, involvirg (NH^)^SO^ 
fractionation, various phosphate elutions from DEAE-Sephadex 
columns, preparative disc gel electrophoresis, and further 
gel filtration on Sephadex G-100 or G-200, uniformly resulted 
in large losses in GAD activity, and no further increase in 
specific activity. Reasons for this apparent enzyme in­
stability and methods to cope with this problem are dealt 
with in the Discussion section.
Isolation and Assay of GAD on 
Polyacrylamide Gels
The partially purified GAD preparation was analyzed 
on polyacrylamide disc gel electrophoresis to identify the 
GAD band. Electrophoresis was performed as described in 
Methods, the most critical stage being pre-electrophoresis 
of the separating gel to remove persulfate oxidizing activity. 
When this was not performed sufficient oxidizing activity 
was retained in the gel to denature the enzyme and resulted 
in an inability to detect GAD enzyme activity in gel slices.
The best separation of protein bands was obtained using 
a 3*5% gel, at pH 9,5 . Gels were stained at neutral pH, with 
minimal surface denaturation by ANS (Hartman and Udenfriend, 
19 69)- Freshly run disc gels were removed from their tubes 
and immersed in the ANS solution in a Petri dish. The 
protein bands were then observed under a ultraviolet lamp 
as yellow fluorescent bands. Gels were then slicedinto 2- 
mm pieces and placed in tubes containing buffer to bring 
the pH to that necessary for enzyme assay. Gel slices were
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individually assayed as described in Methods.
Figure 5 shows the protein separation obtained with 
a 3.5% acrylamide gel at pH 9*5* Also the results of assays 
for GAD activity of that gel are shown. GAD enzyme activity 
coincides with one major protein band located 7 mm from the 
dye front. GAD enzyme activity was also determined by sli­
cing individual bands under direct visualization by an ul­
traviolet lamp. These individual protein bands were then 
assayed as usual with the detection of enzyme activity con­
firming the position of the GAD protein.
Although the GAD enzyme protein was detectable as a 
single band after electrophoresis on 3*5^ gels at pH 9 .5  
this does not mean that this band represents a homogeneous 
protein. To determine the purity of GAD in that specific 
band sufficient numbers of standard gels (approximately 50 
gels) were run and the GAD bands sliced from each after 
visualization with ANS and ultraviolet light. These were 
pooled, homogenized (see Methods) and re-electrophoresed.
The re-electrophoresis of a presumably pure protein at 
multiple pH's and percentages of acrylamide should demonstrate 
the homogeniety of the sample if in fact it is a single 
protein. Since the basis of protein separation in disc gel 
electrophoresis is by molecular weight and charge, it is 
possible that two proteins of differing charge may migrate 
to the same staining position on disc gels if the proteins 
have compensating molecular weight characteristics. Thus, 
the re-electrophoresis of the GAD band under varying pH's
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Pig. 5» Oise electrophoresis of partially purified GAD 
in acrylamide gels at pH 9 .5 and the assay for 
GAD enzyme activity of that gel
The protein pattern is on the top of the figure. A 
100 jig protein fraction from the Sephadex G-100 column was 
loaded onto a 3*5^ acrylamide , pH 9 .5 gel. The gel is shown 
with the origin to the right, the dye front to the left.
Full details for electrophoresis and GAD enzyme assay are 
given in Methods.
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and gel percentages would indicate if contaminating proteins 
were present.
The re-electrophoresis described above was performed 
in 3«5» 5*25* 7.0, and 10.5 percent acrylamide gels at pH 
9.5* Figure 6 shows the re-electrophoresis of the GAD band 
at multiple percentages of acrylamide. One major protein which 
coincided with GAD activity was found at all acrylamide per­
centages with extremely minor contaminants visible in the 10.5% 
gel in the immediate vicinity of the GAD enzyme protein. Stain' 
ing of the 5*25% gel with ANS and slicing of the band under 
ultraviolet lamp illumination, followed by enzymatic assay of 
the gel (Fig. 6), confirms that the original protein band (Fig. 
5) at 7 mm on the 3*5%* pH 9*5 gel is indeed the GAD enzyme 
protein. Figure 7 shows the re-electrophoresis of the GAD en­
zyme protein in a 7% gel in two different anodic gel systems, 
pH 10 and pH 9*5* In each case only one major band is present 
thus supporting the previous results on the homogeneity of the 
GAD protein as isolated on disc gel electrophoresis. Figure 
8 shows the re-electrophoresis of the GAD enzyme protein at 
multiple percentages of acrylamide in the pH 10 system which 
further supports the above conclusion.
Immunochemical Analysis 
With the homogeneity of the electrophoretically obtained 
GAD protein established a large scale isolation procedure 
for the enzyme was carried out. Preparations from the G-100 
column were run in sufficient numbers on 3*5% pH 9 . 5  gels
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Fig. 6. Re-electrophoresis of the GAD band at multiple 
percentages of acrylamide at pH 9 .5 and the 
enzyme assay of those gels
The protein patterns are on the top of the figure.
The gels are shown with the origin to the right, the dye front 
to the left. Full details for re-electrophoresis and GAD 
enzyme assay are given in Methods. From top to bottom the 
samples ares 3*5^» 5*25^, 7-0%, 10.y/o. Enzyme assay was done 
on the 5 *25% gel.
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Fig. 7. Re-electrophoresis of the GAD band in 7% gels 
in the pH 10 and pH 9 . 5 anodic systems
The gels are shown with the origin to the top, the 
dye front to the bottom. Full details for re-electrophoresis 
are given in Methods. Left gel is pH 10; right gel is pH 9*5*
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Fig. 8. Re-electrophoresis of the GAD band at multiple 
percentages of acrylamide at pH 10
The gels are shown with the origin to the top, the 
dye front to the bottom. Full details for re-electrophoresis 
are given in Methods. From left to right the samples are* 
3>5%>* 5*25°/°t 7*0%, 10.5% acrylamide.
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so that 250 of pure enzyme per inoculating dose could be 
prepared. This required the electrophoresis of approximately 
850 standard gels to isolate large enough quantities of GAD 
protein for injection. The injection protocol is described 
in the Methods section. Antisera from rabbits receiving 
a total of 850 ^ g of purified bovine GAD were used in all 
subsequent experiments.
To determine if the anti-GAD sera were monospecific 
micro double immunodiffusion plates were employed. The an­
tigens used were the partially purified bovine GAD, bovine 
brain homogenate, and mouse brain homogenate. Figure 9 
shows the results of this experiment. This plate was re­
frigerated overnight and washed in 0.9$ NaCl to clear the 
non-precipitating proteins. The antisera to GAD isolated 
from bovine cerebellum were found to react with the decar­
boxylase from mouse brain with a reaction of identity. A 
sharp precipitin band was observed with the partially purif­
ied bovine GAD as an antigen (Figure 9k), The anti-GAD sera 
also gave a single sharp precipitin line with the bovine 
brain -(Figure 9B) and mouse brain (Figure 9C) homogenates.
Sera from unimmunized rabbits gave no precipitin band on a 
micro double immunodiffusion plate. The results shown in 
Figure 9B and 9C demonstrate that the anti-GAD antisera were 
monospecific for GAD and did not contain detectable quantit­
ies of precipitating antibodies to any other proteins found 
in brain homogenates.
Prior to further comparisons between bovine and mouse
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Pig. 9* Monospecificity of rabbit anti-bovine GAD sera 
on a micro immunodiffusion plate
Anti-GAD sera were obtained as described in Methods. 
The center wells contain anti-bovine GAD sera. Antigen is in 
outer wells. A» partially purified bovine GAD adjusted to 
1.^5 mg protein/ml; B» bovine cerebellum homogenate adjust­
ed to 7*0 mg protein/ml; C: mouse brain homogenate adjusted
to 5* 0 mg protein/ml.
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glutamic acid decarboxylase an experiment was conducted to 
determine if GAD enzyme activity was linear with respect to 
the quantity of mouse brain homogenate assayed. Figure 10 
indicates that the assay used for a bovine homogenate also 
gave a valid estimation of GAD enzyme activity in a mouse 
brain homogenate. The assay was highly reproducible from 
one preparation to the next.
Thermal Stability 
Experiments were performed to study the stability of 
the enzyme with time at various incubation temperatures.
The stability of GAD at C, 30° C, 40° C, and 50° C from
bovine brain, ^ day old mouse brain, and 20 day old mouse 
brain were determined. Different ages of mouse brain were 
chosen to determine if there was a difference between GAD 
stability in the young and older mice. Figure 11 shows the 
results of this experiment. For all brain extracts incu­
bated at 50° C enzyme activity is reduced to less than 10% 
of initial activity by 1 hour. At incubation temperatures 
of 30° C and ^0° C the bovine brain GAD appeared to decrease 
less in enzymatic activity than the mouse preparations.
After a 4 hour incubation period at 30° C, 60% of the bovine 
GAD activity remained while at 4-0° C, 52% of the activity 
was retained. At the same time periods, the mouse prepar­
ations retained only between 35-50% initial activity at 
30° C, and 8-20% initial activity at 4-0° C. Results of 
thermal stability at C were similar for all brain extracts, 
ranging between 75-93$ of initial activity being retained.
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Fig. 10. GAD enzyme activity with respect to protein 
concentration of a mouse brain extract
The mouse brain homogenate was prepared as described 
in Methods.
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Fig. 11. Thermal stability of a bovine and mouse brain 
GAD
Brain preparations were adjusted to 4 mg protein per 
ml and incubated at various temperatures. Percent initial 
GAD enzyme activity is shown as a function of time at 4-° C 
( A ), 30° C ( □ ), 40° C ( ■ ), 50° C ( * ). At bovine 
cerebellum; Bi 4- day old mouse brain; Cs 20 day old mouse 
brain.
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pH Optimum
The activity of GAD at various pH's was studied using 
brain preparations from bovine cerebellum, 4 day old mouse, 
and 20 day old mouse. Aliquots of brain preparations were 
adjusted to pH values between 5*7-7*9 and assayed for GAD 
activity. The results (Figure 12) show the optimal pH 
for GAD enzyme activity was 6.8 for all preparations.
Effects of Potassium on GAD Activity 
The effect on mouse brain GAD activity of the addition 
of potassium chloride or potassium phosphate to 50 mM 
potassium phosphate buffer was studied for a 18 day old 
mouse brain. The results of the experiment (Figure 13) 
show that- KC1 added to 50 mM potassium phosphate is much 
more inhibitory than equimolar amounts of potassium phosphate. 
Similar results were obtained with NaCl showing that inhibi­
tion could be attributable to Cl~ ion.
Inhibition of GAD by Anions 
The inhibition of mouse brain GAD enzyme activity by 
the addition of various concentrations of potassium salts 
was examined. The following compounds were evaluated for 
their inhibitory effects at concentrations between 0 .05-0 .35 Mi 
potassium acetate, potassium chloride, potassium nitrate, 
potassium sulfate, potassium iodide, and potassium fluoride.
The enzyme was pre-incubated with inhibitor at room-tempera- 
ture for 1 hour prior to the addition of the substrate. The 
results (Figure 14-) of this experiment show that at low con-
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Fig. 12. The effect of pH
Brain homogenates were 
ml. Ai bovine cerebellum; Bi 
20 day old mouse brain.
on bovine and mouse brain GAD
adjusted to k mg protein per 
^ day old mouse brain; C»
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Fig. 13. Effect of potassium on mouse brain GAD activity
18 day old mouse brain extracts were adjusted to ^ 
mg protein/ml. Percent initial GAD enzyme activity is shown 
as a function of K-phosphate ( • ) molarity, KC1 ( ■ ), and 
NaCl ( o ).
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Fig. Ik. Inhibition of mouse brain GAD enzyme activity 
by the addition of various concentrations of 
potassium salts
18 day old mouse brain extracts were adjusted to k 
mg protein/ml. Percent initial GAD enzyme activity is shown 
as a function of K-salt molarity for* KF ( ^ ), KCgH^O,, ( ■ ), 
KC1 ( o ), KN03 ( • ), K2S04 ( □ ), KI ( a ).




















K - s a l t  m o la r i t y
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
64
centrations KI is the most potent inhibitor followed by KgSO^, 
KNO^, KC1, KCgHjO^t and KF. At concentrations of KNO^ and 
KC1 above 0.05 M the inhibition of GAD increases while 
reaches a maximum of inhibition at 0.4 M.
Table 2 summarizes the data of Figure 14 including a 
comparison of inhibition by those compounds of bovine cere­
bellum, 19 day old mouse brain, pig, sheep, and human brain 
GAD. Inhibition of GAD activity was examined at a 0.1 M 
concentration of all compounds. There is approximately equal 
inhibition of the various brains' GAD enzyme activity by each 
of the compounds studied.
Inhibition of GAD by Various Compounds 
An initial experiment was performed to determine the 
extent of inhibition of GAD by various compounds between 
the concentrations of 0.001-1.0 mM. The following compounds 
were examined at an inhibitor concentration of 0.3 mM for 
their effect on mouse and bovine GAD enzyme activity* 
hydroxylamine, iodoacetamide, 1,2-napthoquinone-4-sulfonic 
acid, nitroso R salt, aminooxyacetic acid, and p-h\droxy- 
mercuribenzoic acid. As in the previous study the enzymes 
were pre-incubated at room-temperature for one hour in the 
presence of the inhibitor compound. Table 3 indicates 
the results of this experiment. 1,2-Napthoquinone-4- 
sulfonic acid is the most potent inhibitor of both glutamic 
acid decarboxylases, whereas iodoacetamide and hydroxylamine 
are the weakest inhibitors. In each of these cases the in­
hibitors affect bovine and mouse glutamic acid decarboxylase












TABLE 2. COMPARISON OF INHIBITION BY POTASSIUM SALTS OF 
BOVINE CEREBELLUM, 19 DAY OLD MOUSE BRAIN, PIG,




Pot. Phos. 19 26 14 11 +9
KC1 52 52 45 24 42
NaCl 38 51 36 44 36
KI 92 94 87 90 72
KF 47 0 4 21 35
k c 2h 3o 2 17 18 +17 29 28
K ^ O i* 70 68 55 70 73
k n o 3 71 70 59 57 46
*A11 values are for 0.1 M concentration of the salt.
100% activity is that in 0.05 M potassium phosphate buffer.
On
TABLE 3. COMPARISON OF INHIBITION BY VARIOUS
COMPOUNDS OF BOVINE CEREBELLUM AND 19 
DAY OLD MOUSE BRAIN GAD ENZYME ACTIVITY
Inhibition %_ 
Compound (0.3 mM) Mouse Bovine
Hydroxylamine 12 11
Iodoacetamide 18 11
1,2-Napthoquinone-4-sulfonic acid 100 97
Nitroso R salt 65 94
Aminooxyacetic acid 62 78
p-Hydroxymercuribenzoic acid 59 84
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
67
activity to a similar extent. Although differences in in­
hibition of the two mammalian glutamic decarboxylases may 
be noted for aminooxyacetic acid, nitroso R salt, and 
p-hydroxymercuribenzoic acid, each of these compounds appear 
to be more potent inhibitors of the bovine GAD than of the 
mouse GAD.
Effect of Pyridoxal-5'-Phosphate on GAD Activity
GAD activity was studied as a function' of pyridoxal-5'- 
phosphate concentration (Figure 15). All assays systems were 
pre-incubated for 2 hours at room-temperature to allow in­
teraction of pyridoxal-5*-phosphate with GAD. For all three 
preparations maximal GAD enzyme activity was exhibited at the 
same pyridoxal-5'-phosphate concentration. Maximal activity 
of GAD enzyme activity occurred at a 0.025 mM pyridoxal-5'- 
phosphate concentration for both the k and 28 day old mouse 
GAD. A plateau of maximal activity of GAD exists between a 
0.010-0.025 mM concentration for the bovine cerebellum GAD.
On either side of the optimum concentration of pyridoxal-5'- 
phosphate GAD enzyme activity rapidly decreased.
Glutamate Decarboxylase in Developing Mouse Brain
GAD specific activity was examined at various postnatal 
ages of developing mouse brain between 1 and 90 days. Mice 
(C57BL/6J) were maintained as described in Methods. A min­
imum of three brains were used at any age point. Brains 
were homogenized (Duall homogenizer, Kontes Glass Co. ) in
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Pig. 15* Effect of pyridoxal-5'-phosphate concentration 
on GAD activity
All enzyme preparations were adjusted to 4 mg protein 
per ml. GAD activity is shown as a function of the log of 
pyridoxal-5'-phosphate concentration between 0.001-4 mM.
A* 4 day old mouse brain; B* 28 day old mouse brain; C: 
bovine cerebellum.
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2.5 volumes of potassium phosphate buffer A, centrifuged at 
35•000 x g for 20 min at 4° C and the post-mitochondrial 
supernatant fraction retained. This fraction was assayed 
for GAD activity.
Figure 16 shows the results of this experiment express­
ing units of GAD specific activity in two alternative forms:
Figure 16A expresses units of enzyme specific activity as
/ 1 4CPM in C02 released from L-(l- Cjglutamic acid per mg pro­
tein; Figure 16B contains the enzyme activity expressed as 
CPM in C02 released from L-(l-^C) glutamic acid per gram wet 
weight tissue. Both show an initial rise in specific activity 
occurring at 6 days postnatally followed by a rapid increase 
in enzymatic acitvity which reaches a maximum at 28 days post­
natally. GAD specific activity decreases between 28-40 days, 
then the level of enzyme activity shows a slight rise for the 
period of time between 40-90 days postnatally. Considering 
both pieces of data, GAD enzyme specific activity appears to 
increase 12-15 fold between 6 and 28 days in mouse brain de­
velopment then decreases to an activity that is approximately 
10 fold higher than the initial activity of enzyme found at 
one day after birth.
Quantitative immunoprecipitation determinations of 
mouse GAD using rabbit anti-bovine GAD antisera were per­
formed at various ages of developing brain as described in 
Methods. However, before this study was undertaken a pre­
liminary experiment was designed to evaluate the ability of 
anti-GAD antisera to inhibit GAD. It is of importance
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Fig. 16. GAD activity during postnatal development in 
mouse brain
Mouse brain extracts were prepared as described in 
text. Three mice (C57BL/6J) were used at any age point. A:
CPM in COg released from L-(l- C)glutamic acid per mg protein;
1 ii,
B: CPM in CO^ released from L-(l- C)glutamic acid per gram 
wet weight tissue.
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to determine if a relationship exists between inhibition of 
GAD enzyme activity and increasing concentrations of anti- 
GAD sera prior to using the antiserum for enzyme protein 
quantitation. The results (Figure 1?) indicate that the 
inhibition of enzyme activity by sera is not a totally lin­
ear effect. A maximum of 90% inhibition of partially pur­
ified bovine cerebellum GAD (Figure 17A) and of a mouse brain 
GAD (Figure I7B) was obtained. Increased concentrations 
of anti-GAD sera did not result in further inhibition of 
the enzyme. Therefore, calculations for quantitative im- 
munoprecipitation data were made at dilutions of anti-GAD 
sera where the inhibition of GAD activity was linear with 
respect to immune sera concentration.
The results of tne experiment on the quantitative 
immunoprecipitation of GAD in developing mouse brain are 
shown in Figure 18. The amount of protein in the immune 
precipitate per brain at each age point increases 10 fold 
over the period between 1-28 days postnatally, then decreases 
to approximately 7 fold of initial GAD enzyme protein levels 
at more mature ages. The volume of anti-GAD antisera re­
quired for complete inhibition of all GAD enzyme activity 
per brain at each age point increases to 9* 5 times initial 
quantities by 22 days postnatally. Between 22-90 days the 
quantity of sera required for total GAD inhibition decreases 
to 7 fold then slowly increases to 11 times initial quanti­
ties.
The superimposition of the GAD enzyme activity profile
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Fig. 17. Inhibition of partially purified bovine GAD
and mouse GAD enzyme activity by rabbit anti- 
bovine GAD sera
Inhibition of GAD activity by anti-GAD sera was per­
formed as described in Methods. GAD activity ( o ) in the 
supernatant after immunoprecipitation; percent inhibition of 
initial GAD activity ( • ). As partially purified bovine 
cerebellum GAD; B: mouse brain homogenate.
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Fig. 18. Quantitative immunoprecipitation of GAD in 
developing mouse brain
Quantitative immunoprecipitations were performed as 
described in Methods. Micrograms of protein in the immune 
precipitate per brain ( ■ )i microliters of anti-GAD antisera 
required for complete inhibition of all GAD enzyme activity 
per brain (a ).
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(Figure 16) onto the data just presented (Figure 18) indi­
cate that both profiles closely coincide. Both indicate 
that initial rises in GAD occur at day 6 with maximal levels 
reached between 22-28 days postnatally. "Mature" levels of 
the enzyme appear to exist between 28-90 days.
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DISCUSSION
Studies with a crude mouse brain extract have shown 
that GAD is a sulfhydryl enzyme and requires PyP for enzyme 
activity (Roberts and Frankel, 1951; Roberts and Simonsen, 
1 9 6 3). In 1966 Susz, Haber, and Roberts were able to ac­
complish a partial purification of GAD from mouse brain by 
the use of a combination of PyP and 2-aminoethyl-isothiour- 
onium bromide (AET) which stabilized the enzyme for long 
enough periods to allow a purification to be performed.
It had previously been discovered that pyridoxal-5'- 
phosphate requiring enzymes, in general, exhibit an inactiv­
ation by U.V. light or sunlight (Schlenk e£. al. , 19^6), 
and that a soluble preparation of mouse brain GAD at 4° C 
in the presence of glutathione (GSH) and PyP was inactivated 
more rapidly in the light than in the dark. Roberts (1972) 
proposed that the apoenzyme of GAD, as well as the coenzyme, 
may be inactivated by light-induced free radicals since the 
enzyme failed to be reactivated by an excess of PyP. It was 
found that a combination of GSH and PyP, both of which are 
known to react with free radicals, provided partial protection 
of GAD against U.V. inactivation. The examination of other 
radioprotective substances resulted in the choice of AET;
AET had previously been reported to exist in neutral solution 
as 2-mercaptoethylguanidine (Khyme £t. al., 1957)* AET pro­
tected GAD somewhat better from U.V. inactivation than iso­
molar amounts of GSH or dithioerythritol (DTE).
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Spectral data (Buell and Hansen, i960) indicates that 
AET may form a cyclic derivative with PyP, or that AET is 
merely a source of mercaptoethylamine, either of which then 
forms a thiazolidine derivative with the aldehyde moiety of 
PyP.
N H *





From inhibition data Roberts (196*0 postulated the existence 
of a thiazolidine bridge in GAD. The sensitivity to destruc­
tion of the thiazolidine bridge might be expected to be the 
same as that of the active site on GAD. Thus, the probability 
of the active site being destroyed by light-induced free 
radicals might be less in the presence of the thiazolidine 
complex than in the presence of isomolar concentrations of
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GSH and PyP. This theory might explain the greater in vitro 
protection of GAD by AET when compared with sulfhydryl com­
pounds lacking amino groups.
Although previous work (Roberts, 1972) indicates that 
aminothids and AET in particular are superior GAD-protecting 
agents as compared to sulfhydryl compounds, it was found that 
for the experiments described in this work dithiothreitol 
(DTT) provided the greater protection against enzyme inac­
tivation. DTT was found to offer a greater stabilization of 
GAD than 2-mercaptoethanol, DTE, or AET.
The partial purification of GAD has been successfully 
performed from four sources of the protein. Williams and 
Hager (1966) described the purification of GAD from Escherichia 
coli. where the enzyme is inducible when the organism is 
grown in the presence of glutamate (Strausbauch ejt. al. , 1967)* 
It was found that GAD could be isolated as a by-product during 
the actual purification of pyruvate dehydrogenase. The ammon­
ium sulfate-precipitated GAD protein could then be dissolved 
in buffer and recrystallized to purity.
Another purification scheme was developed for GAD from the 
lobster central nervous system. Molinoff and Kravitz (1968) 
utilized a four-stage protocol to obtain a 40-fold purification 
of GAD. A post-mitochondrial extract was selectively precip­
itated between 40-65% followed by gel filtration
and ion exchange chromatography. The major proportion (about 
90%) of the enzyme activity was found in cfthe soluble 3 0 ,0 0 0  
x g supernatant fraction.
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A seven-step procedure for preparing highly purified 
GAD from the anaerobic bacterium, Clostridium oerfringens. 
was developed by Cozzani (1970). A combination of MnCl2 and 
(NH^)2SO^ precipitations followed by gel filtration on Sephadex 
G-100 and G-200 resulted in a 24-fold purification. The ho- 
mogeniety of the pure enzyme was established by starch-gel 
electrophoresis and sucrose-density gradient centrifugation.
The purification of GAD from mouse brain (Wu et. al. , 
1973) was accomplished after the discovery that a combination 
of AET and PyP could stabilize the enzyme for periods long 
enough to allow for a combination of (NH^)2S0^ fractionation, 
gel filtration, calcium phosphate gel and DEAE-Sephadex chro­
matography (see Introduction). However, upon attempting this 
protocol for the purification of bovine GAD it was found that 
(;NH^ )2SO^ precipitation steps resulted in a large loss of to­
tal GAD enzyme activity. This finding is consistent with the
data (Fig. 14 and Table 2) presented in this thesis that the 
2_
SO^ ion is a extremely potent inhibitor of GAD, Because of 
this problem alternative methods of purification and stabiliz­
ation were examined.
Two major differences exist between the Wu (1973) proto­
col and the method finally selected for use. The first was 
the use of DTT in place of AET as a sulfhydryl protective 
agent (see text). As mentioned earlier, although data would 
indicate otherwise (Roberts £t. al., 1972), DTT (1 mM) was 
found to be a better stabilizer of enzyme activity than any 
other aminothiol or sulfhydryl compound tested. The other
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difference was the choice to use a 35»000 x g post-mitochondrial
supernatant fraction. This decision was based on the finding
1 ^that measurement of C02 evolution was not a valid estimate 
of true GAD activity if a mitochondrial fraction was being 
studied. Quantitation of and (^C)GABA produced in a
isotopic assay from (U- C)glutamic acid indicates an increased
1 1f, 4*
CO^ production upon addition of NAD and CoA to assay mix­
tures, via the coupled reactions of glutamic acid dehydrogen­
ase and oc-ketoglutarate dehydrogenase (Drummond and Phillips,
197^) • The addition of 1 mM AOAA to assays inhibited (*\))GABA 
. l i t
production 92?° while CO^ production was inhibited only 537®
(Drummond and Phillips, 197*0• Use of a mitochondria-contain-
ing fraction thus gives too high an estimate of GAD activity.
This was the basis for the use of a post-mitochondrial fraction
for a starting point for the present partial purification of
bovine brain GAD. The study by Drummond and Phillips (197*0
Xindicates that possibly kOfo of all CO,, being evolved and 
absorbed during the incubation could come from reactions oc- 
curing in the tricarboxylic acid cycle, specifically the decar­
boxylation of &C-KG by <=<— ketoglutarate dehydrogenase. The 
use of a combination of AET and PyP by Wu gt. al. (1973) as 
a stabilizer of GAD still resulted in a 99°/° loss of GAD spe­
cific enzyme activity; the present study, as previously men­
tioned, used DTT as a sulfhydryl compound and still experienced 
a 93f° loss of GAD activity.
Attempts to utilize ammonium sulfate for concentrating 
protein (Wu £t. al., 1973) resulted in extremely large losses
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2 _
in total GAD enzyme activity. As mentioned above the SO^ 
anion is a potent inhibitor of both bovine and mouse brain 
GAD enzyme activity. Such losses in total enzyme activity 
prompted the use of a PM-3 0 Diaflow ultrafiltration membrane 
(see text) as the method of choice. This technique resulted 
in rapid concentration of column chromatography fractions 
with a minimal loss in GAD activity.
The examination of the most highly purified fraction of 
mouse brain GAD (Wu et. al., 1973) was performed using poly­
acrylamide gel disc electrophoresis. Prior to electrophore­
sis of GAD, the 3*5$ acrylamide gel (containing Tris-HCl) 
was pre-electrophoresed with a Tris-glycine buffer. The 
purpose of this technique (to reduce the oxidizing agent, 
persulfate) is understandable, however it results in the 
actual electrophoresis of the GAD protein being performed 
in a continuous buffer system; this diminishes the resolution 
power of the method.
We felt that the use of a Tris-phosphoric acid buffer, 
replacing Tris-HCl, would eliminate the inhibitory Cl~ anion 
and that this same buffer (Tris-phosphoric acid) would be 
used for pre-electrophoresis of the separating gel. Thus, 
a discontinuous buffer system (Tris-glycine) could be em­
ployed for the final electrophoresis of GAD, affording in­
creased resolution power. The problems concerning the analysis 
of polyacrylamide disc gel electrophoresis results, with 
reference to homogeneity of a protein band, has been dis­
cussed in the Results section.
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Previous reports have indicated that acrylamide does 
not interfere with antibody production (Sussman ejt. al. , I9 6 8). 
This observation and those of Hartman and Udenfriend (1969) 
prompted a similar methodology for the induction of antibodies 
to bovine brain GAD. The electrophoresis of the partially 
purified bovine brain GAD preparation, followed by the slic­
ing and re-electrophoresis of the GAD protein band allowed for 
the elimination of all contaminating proteins. Thus an elec- 
trophoretically pure protein was used for inoculation of 
rabbits.
Wu ei. ai- (1973) used their most highly purified soluble 
fraction of mouse brain GAD for inoculation into rabbits for 
the induction of anti-GAD serum (Saito and Roberts, 197^).
When this anti-GAD serum was used for Ouchterlony double dif­
fusion analysis a sharp precipitin band was observed with 
purified mouse GAD or a crude mouse brain preparation versus 
the antiserum. In the same study a comparison of Ouchterlony 
double diffusion tests with crude enzyme from various species 
was made. Single precipitin bands were observed with the 
anti-mouse GAD serum and crude brain preparations from rat, 
rabbit, guinea pig, quail, pigeon, and frog. However, the 
precipitin bands from the pigeon, quail, and frog preparations 
showed spurs. Thus, the enzymes from mammalian species were 
indistinguishable by Ouchterlony double diffusion analysis, 
however differences between the mouse enzyme and avian enzyme 
were detectable. When the inhibition of GAD enzyme activity 
(by antibody against mouse GAD) from these different species
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was compared, it was found that the rat enzyme was inhibited 
somewhat less than the mouse enzyme. GAD from other species 
was inhibited to a much lesser extent. Microcomplement fix­
ation studies of GAD from the various species indicated that 
the GAD from mouse, rat, and human were similar (Saito and 
Roberts, 197^). Saito and Roberts (197^) concluded that the 
mouse and rat enzyme resemble each other by double diffusion 
analysis, inhibition studies, and microcomplement fixation 
curves. The GAD of other mammalian species studied appeared 
to be indistinguishable from the mouse enzyme by double dif­
fusion analysis, however the other techniques employed indi­
cate that differences do exist between the enzymes.
Susz gi. al. (1966), after a 158-fold partial purifi­
cation of the mouse brain decarboxylase, noted that the 
enzyme is stable for one hour at 30° and 40° C, whereas a 
rapid loss of activity was noted at 50° 0* The present study 
examines the thermal stability of a bovine brain, 4 day old 
mouse brain, and 20 day old mouse brain GAD. A rapid loss 
of GAD activity at 50° C was noted for both bovine and mouse 
(both ages) GAD. However, the loss of GAD activity was more 
extensive for the mouse enzyme than that reported by Susz 
et. al. (1966). Our data indicates (Fig. 11) that the bovine 
brain decarboxylase appears to be more stable at all temp­
eratures studied than the mouse brain enzyme.
The optimal pH for GAD enzymic activity has been pre­
viously studied for several mouse brain preparations. Susz
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et. al. (1966) reported the pH optimum of a crude GAD prepara­
tion (from mouse brain acetone powder) to be approximately 
6.4, but that GAD activity remained essentially constant be­
tween 6.4-7.2; the most highly purified GAD preparation was 
maximally active at pH 7.2. The pH optimum of the highly 
purified GAD obtained by Wu and Roberts (1973) from adult 
Swiss albino mice gave a relatively sharp pH optimum around 
7.0, For the Balb/c mouse strain, Wilson at. al. (1972) 
found that a pH of 6.8 yielded maximal GAD activity. These 
result compare favorably with a pH of 6.8, which in this study 
was found to yield maximal GAD activity for all extracts.
The pH optimum conditions for GAD from other sources 
has also been determined for: the anaerobic bacterium Clos­
tridium perfringens. 4.7 (Cozzani at. a1*# 1970); GAD from the 
lobster CNS, 8.0 (Molinoff and Kravitz, 1968); the slime mold 
Phvsarum polvcephalum. 5.6-6.0 (Nations and Anthony, 1969).
We cannot survey here the enormous literature relating 
to the effect of various anions and/or cations on the GAD/GABA 
system. The results of this study concerning the inhibition 
of GAD enzyme activity by anions (Fig. 13 and 14, Table 2) 
are in agreement with Susz si. al* (19 6 6) who indicate that 
GAD (mouse) inhibition by anions is in the order 1“ >  NO^ ” >  
S042” y Br“ >  Cl” >  C2H^02“ > F ”. The same study (Susz ai. 
al.. 1966) also showed the inhibition of GAD activity by Cl" 
ions to be competitive with substrate. Interestingly, the 
bacterial enzyme (Shukuya and Schwert, i9 6 0) differs from 
the brain enzyme by being activated by anions.
Chloride ions could have a physiological function of
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regulating brain GAD activity. The role of glutamate as a 
potential excitatory compound in both vertebrate and inver­
tebrate synaptic clefts, and GABA (which is made from glutamate 
by GAD) as a putative inhibitory neurotransmitter has been 
discussed in the Introduction. Since the actual values for 
extracellular (0.1 M) and intracellular (0.02 M) concentrations 
of Cl" ion also fall within a range of concentration that 
affect GAD activity in the present study, it is conceivable 
that variations in Cl” ion concentration at the pre-synaptic 
nerve terminal could control the relative ratio of glutamate: 
GABA by the regulation of GAD enzyme activity. Thus, the 
predominant compound to be released into the synaptic cleft 
upon stimulation of the pre-synaptic nerve terminal (see 
Srinivasan £t« al. , 1969. concerning the efflux of -^H-GABA 
from brain slices) could be regulated by Cl” ion concentra­
tion. Thus the Cl” ion concentration could determine whether 
a nerve ending, when stimulated, has an excitatory (glutamate 
release) or inhibitory (GABA release) function.
Two previous studies support the above theory for the 
regulation of the rate of transmitter biosynthesis by Cl” ion. 
Potter £i. al. (1968) has shown that the biosynthesis of 
acetylcholine, even though regulated by feedback control of 
acetylcholine acetylase, may also be influenced by the ionic 
composition of the axoplasm. Also, a neurophysiological study 
(Kandel al.» 1967) on Apivsia californica (a marine mollusc) 
ganglion showed that the terminal branches of a single cho­
linergic neuron produce both inhibitory and excitatory effects
Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
8 9
on different post-synaptic cell membranes.
Extensive experiments have been conducted on the inhibi­
tion of GAD by substances which react with sulfhydryl groups, 
and by inhibitors that combine with the aldehyde moiety of the 
coenzyme, pyridoxal-5 '-phosphate (see articles* Roberts and 
Simonsen, 1963; Tapia et.. al. , 1966* Tapia and Awapara, 1969; 
Tapia and Sandoval, 1971)* Shukuya and Schwert (i9 6 0) in a 
study of the bacterial decarboxylase, suggest that it is a 
sulfhydryl enzyme (also see Strausbauch and Fischer, 1970, 
for a sulfhydryl group titration study). The sensitivity to 
oxygen and protection by GSH, DTT, or 2-mercaptoethanol of 
the brain decarboxylase (Roberts si. ai* » 1972) suggest it too 
contains a sensitive sulfhydryl group, the physical integrity 
of which is essential for the maintenance of enzymatic ac­
tivity.
The complex kinetics of reactions catalyzed by PyP re­
quiring enzymes has been considered by Roberts and Simonsen 
(1 9 6 3) in the following reaction sequence* A— PyP; E— GAD;







Reproduced with permission o f the copyright owner. Further reproduction prohibited w ithout permission.
9 0
The inhibitor compounds considered in this study react 
with the sulfhydryl groups in GAD, each in a specific manners 
iodoacetamide is an alkylating agent; p-hydroxymercuribenzoic 
acid is a mercaptide forming reagent; 1,2-napthoquinone-^- 
sulfonic acid and nitroso R salt form adducts with sulfhydryl 
groups (see Roberts and Simonsen, 1963* for detailed discuss­
ion of inhibitors). Matsuo and Greenberg (1959) have shown 
that the final two compounds are also inhibitors of cystathion- 
ase, another PyP requiring enzyme. That these final two com­
pounds inhibit GAD in a competitive manner (Matsuo and Green­
berg, 1959) with respect to substrate concentration suggest 
that a sulfhydryl moiety may be at or near the enzyme's ac­
tive site.
Another much larger group of inhibitors of PyP requir­
ing enzymes are the carbonyl trapping agents which inhibit 
enzyme activity by combining with the aldehyde group on the 
coenzyme, pyridoxal-5'-phosphate. For a thorough discussion 
on the inhibition of the decarboxylase by AOAA, hydroxylamine, 
and related compounds see the articles cited at the beginning 
of this section.
The changes in GAD enzyme activity during postnatal de­
velopment in mouse brain are paralleled by rapid alterations 
in brain morphology. At birth, the process of differentiation 
of neuroblast to neuron is largely completed. During the first 
postnatal week a transition occurs from a time when differ­
entiation is the major process occur&ig to a period when growth 
and maturation of neuronal elements predominates. The second
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and third weeks of postnatal brain development are marked by 
increases in the size of cell bodies which are now becoming 
rapidly separated by expanding dendritic processes. There 
also appears an increased prominence of Nissl granules, a 
corresponding decrease in nuclear DNA, and increased myelina- 
tion of the axons of major fiber tracts. These changes occur 
throughout the whole brain but are most noticeable moving 
from hindbrain toward the cerebral hemispheres. For a re­
view of the development of the nervous system see The Neuro­
sciences, second study program (Schmitt, 1970).
Comparisons of postnatal morphological changes in rat 
brain with those of mouse reveal that the two species are 
similar, allowing comparisons of enzymatic activity changes 
between the species. Sugita (1917) compiled a detailed and 
precise timetable for morphological changes in rat brain; 
during the first 10 postnatal days significant increases 
occur in cortical thickness, lamination and cell number. In 
the rat, the time period of greatest increase in GAD levels 
is during the second and third week of postnatal brain devel­
opment (Van Den Berg si. aJL., 1965; Bayer and McMurray, 1967; 
Sims and Pitts, 1970). During the first month of postnatal 
life GAD activity in rat brain increased approximately 10- 
fold (Sims and Pitts, 1970). The increase in GAD specific 
enzyme activity presented in this study is nearly identical 
to that reported by Sims and Pitts (1970).
The initial rapid increase in GAD enzyme levels, which 
begins by day 6 (see Figs. 16 and 18) precedes a burst of
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whole brain protein synthesis which begins on day 11 (Pitts 
and Quick, I96 7). The rate of brain RNA synthesis begins to 
increase by day 6 (Balazs et. al., 1968) and thus the accel­
erated synthesis of GAD and SSA-DH (Pitts and Quick, 1967), 
which begin to rise at day 6, are among the first enzymes to 
reflect this increased amount of RNA.
Potter £t. al. (19^5) measured SSA-DH and ATPase activ­
ity in developing rat brain; the general form of the GAD 
activity profile in our study closely resembles the enzyme 
activity curves in their study. The activity of acetylcho­
linesterase (Cohn and Richter, 1956) and ATPase (Samson and 
Quinn, 1967) have both been shown to increase rapidly prior 
to the 10th postnatal day in rat brain. SSA-DH (Pitts and 
Quick, I967) and GABA-T (Sims et.. al. , 1968) enzyme activity 
profiles each follow a characteristic course during the devel­
opment of the rat brain.
It appears, therefore, that the period of maximum in­
crease in glutamic acid decarboxylase activity is correlated 
to the period of maturation of the nuclear masses and fiber 
tracts of the central nervous system.
The correlation of changes in GAD activity with GABA 
levels has been examined in a single brain structure, the 
chick optic lobe, during embryonic development and post-hatch­
ing (Sisken a£. al., 1961). At the 7-day embryo stage the 
levels of GAD and GABA are among the first detectable and 
increases in GAD activity are proportional to increases in 
GABA levels; mature levels of enzyme and product are attained
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between 5-10 days post-hatching. Roberts and Kuriyama (1968) 
have shown in chick cerebellum that GAD activity increased 
most rapidly just prior to hatching, a period during which 
the cerebellum experiences the most rapid proliferation of 
dendritic growth.
A unique feature of the work presented here is that it 
is the first study to examine whether the increase in GAD 
enzyme activity observed over mouse brain development (Fig. 16) 
represents an increase in the absolute amount of GAD enzyme 
protein. The quantitative immunoprecipitation of GAD in de­
veloping mouse brain by rabbit anti-bovine GAD antisera in­
dicates that the amount of protein in a immune precipitate 
per brain increases 10 fold over the period between 1-28 days 
postnatally (Fig. 18). Such an increase closely coincides 
with the GAD enzyme activity profile (Fig. 16). Therefore, 
we conclude that the increase in GAD specific enzyme activity 
over the development of mouse brain represents an increase 
in the abselute amount of GAD enzyme protein.
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